James R. Kasinger - 10 Sep 2021 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: General Counsel and Secretary
Signature: /s/ Michael Esposito, attorney-in-fact
Issuer symbol: CRSP
Transactions as of: 10 Sep 2021
Net transactions value: -$558,774
Form type: 4
Filing time: 14 Sep 2021, 21:45:31 UTC
Next filing: 18 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRSP	Common Shares	Options Exercise		+10,000	+42%		33,911	10 Sep 2021	Direct	F1, F2
transaction	CRSP	Common Shares	Tax liability	$558,774	-4,741	-14%	$117.86	29,170	13 Sep 2021	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Restricted Stock Units	Disposed to Issuer		-10,000	-100%		0	10 Sep 2021	Common Shares	10,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021.
F2	Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F3	Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.